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OBJECTIVES: Under a constant inspired concentration, the uptake of a volatile anesthetic into the arterial blood
should mainly be governed by alveolar ventilation, according to the assumption that the patient’s cardiac output
remains stable during anesthesia. We investigated whether ventilation volume affects the rate of desflurane uptake
by examining arterial blood concentrations.
METHOD: Thirty female patients were randomly allocated into the following three groups: hyperventilation,
normal ventilation and hypoventilation. Hemodynamic variables were measured using a Finometer, inspiratory and
end-tidal concentrations of desflurane were measured by infrared analysis, and the desflurane concentration in the
arterial blood (Ades) was analyzed by gas chromatography.
RESULTS: During the first 10 minutes after the administration of desflurane, the Ades was highest in the
hyperventilation group, and this value was significantly different from those obtained for the normal and
hypoventilation groups. In addition, hyperventilation significantly increased the slope of Ades-over-time during the
first 5 minutes compared with patients experiencing normal ventilation and hypoventilation, but there were no
differences in these slopes during the periods from 5-10, 10-20 and 20-40 minutes after the administration of
desflurane. This finding indicates that there were no differences in desflurane uptake between the three groups
after the first 5 minutes within desflurane administration.
CONCLUSIONS: Hyperventilation accelerated the rate of the rise in Ades following desflurane administration, which
was time-dependent with respect to different alveolar ventilations levels.
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INTRODUCTION
Theoretically, the passage of a volatile anesthetic from the
alveolar space into the bloodstream depends on several
factors, including the inspired anesthetic concentration,
ventilation volume, blood-gas partition coefficient, and
cardiac output (1-5). Under a constant inspired concentra-
tion, the uptake of a volatile anesthetic into the arterial
blood should be governed mainly by alveolar ventilation,
according to the assumption that a patient’s cardiac output
remains stable during anesthesia (5).
Compared with the routinely monitored variable of end-
tidal concentration, the arterial concentration of a volatile
anesthetic is more likely to represent its concentration in
the brain and therefore can be measured to reflect the
pharmacological effect of the drug. Our previous study
demonstrated that the application of increased alveolar
ventilation led to elevated arterial blood isoflurane concen-
trations at the time of the initial administration of isoflurane
and therefore resulted in its accelerated uptake into the
body (6). Similarly, Enekvist et al. demonstrated that ven-
tilation with larger tidal volumes under isocapnia increased
the rate of the rise in the arterial blood concentrations of
sevoflurane compared with the normal tidal volumes (7).
Desflurane has been widely used for clinical anesthesia due
to its low blood solubility and rapid kinetic characteristics,
which permit a more rapid induction and emergence from
anesthesia (8,9). However, no studies to date have examined
the effect of ventilation on the rate of the rise in the arterial
blood desflurane concentration (Ades). Thus, the current
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study hypothesized that hyperventilation could accelerate
the increase in the arterial blood concentration of desflurane
to achieve the expected anesthetic depth following intuba-
tion in gynecologic patients.
MATERIALS AND METHODS
Patients
Our institutional ethical committee on human research
approved the study protocol, and informed consent was
obtained from each patient. Patients with known pulmonary
or cardiovascular diseases were excluded. Thirty female
patients, who were classified as physical status I according
to the American Society of Anesthesiology and who were
scheduled to undergo elective gynecologic surgery under
general anesthesia, were recruited for the study. These
patients were randomly divided into three ventilation
groups: hyperventilation, normal ventilation, and hypoven-
tilation. There were three study groups and seven sampling
times for the arterial blood desflurane concentrations of
each subject. In total, 210 correlated data entries were
collected. Generalized estimating equations (GEEs) were
introduced as a powerful method to deal with correlated
data in applied science (13).
Anesthetic management
Anesthetic premedication consisted of intravenous fenta-
nyl (2 mg.kg-1) and midazolam (40 mg.kg-1). Under local
anesthesia with 2% xylocaine, a 20-gauge catheter was
inserted into the left radial artery for blood sampling.
Anesthesia was induced with thiopental (4-6 mg.kg-1), and
intubation was facilitated by pretreatment with cis-atracur-
ium (0.1 mg.kg-1) and succinylcholine (1.25 mg.kg-1). After
tracheal intubation, a fixed inspiration of 6% desflurane with
a 6 L min-1 oxygen flow was administered. With a fixed
respiratory rate of 10 min-1, hyperventilation was achieved as
an end-tidal CO2 (ETCO2) of approximately 30 mmHg by
adjusting the tidal volume to 8-12 ml.kg-1. The ETCO2 goals
were 40 mmHg for the normal ventilation group and
50 mmHg for the hypoventilation group and were achieved
by adjusting the tidal volumes to 5-7 and 3-4 ml.kg-1,
respectively. In each patient, the surgical procedure was
initiated after the 40-minute ventilation study was completed.
Anesthetic gas monitor
The anesthesia machine used in this study was an Aestiva/
5 with a 7100 ventilator (Datex-Ohmeda, Louisville, CO,
USA), and soda lime was used as the CO2 absorber. The
leakage of each system was determined by measuring
constant pressure ventilation in a test lung. All results were
corrected for any specific leak observed. The anesthetic gas
concentrations, inspiratory desflurane concentration (CIdes)
and end-tidal desflurane concentration (CEdes), were mon-
itored with a multi-gas analyzer (Aestiva/5 Anesthesia
System; Datex, Helsinki, Finland). The multi-gas analyzer
was calibrated according to the manufacturer’s recommen-
dations.
A total of 10 ml of arterial blood was obtained from each
patient prior to induction to obtain individual blood/gas
partitions (l) and calibration curves of desflurane. At time 0
(before intubation) and at 1, 3, 5, 10, 20, 30, and 40 minutes
after intubation, exactly 1.0 ml of arterial blood was drawn
from the catheter into a heparinized syringe and then placed
immediately in a 10-ml glass vial and tightly sealed. The
blood samples were stored at 4 C˚, and the measurements
were collected within 24 hours. All blood samples were
analyzed for desflurane concentration using gas chromato-
graphy, according to the method described in our previously
published study (5). An additional analysis to determine the
arterial blood CO2 concentration using the Ultima Gas
Analysis Machine (ABBOTT i-STAT, East Windsor, NJ) was
performed at 20 and 40 minutes following desflurane
administration. A thermistor inserted into the nasal pharynx
was used to measure body temperature, which was main-
tained between 35.5 and 37.5 C˚ during the study.
Determination of hemodynamic and respiratory
variables
The hemodynamic parameters were monitored using a
FinometerH (FMS, Finapres Measurement Systems, Arnhem,
Netherlands) (10), which provides continuous, non-invasive
measurements of blood pressure, heart rate, stroke volume,
cardiac output, cardiac index, and total peripheral vascular
resistance. The baseline blood pressure measurements were
calibrated prior to data collection. Hypotension, which was
defined as a decrease in blood pressure of 25% or more from
the baseline value, was treated with intravenous fluid and
intravenous ephedrine (5 mg bolus). The minute ventilation
was calculated as the expiratory tidal volume multiplied by
the respiratory rate. The minute alveolar ventilation (MAV)
was derived from the minute ventilation, as described in
previous publications (11,12).
Determination of arterial blood desflurane concentration
over time (the slope of Ades-over-time). The slope of Ades-
over-time was calculated at time intervals of 1-5, 5-10, 10-20,
and 20-40 minutes after desflurane administration, which
represented the rate of desflurane uptake according to the
speed of the desflurane vapor that passed from the alveolar
space into the circulating arterial blood during each time
interval.
Determination of Blood Desflurane Concentration
Before determining the desflurane concentration in the
blood, 10 ml of blood from each patient was collected to
determine the blood/gas partition coefficient (l) of desflur-
ane for each patient (I) (5). The desflurane level in each
blood sample was converted to the corresponding concen-
tration based on the gas chromatographic measurements
and the blood/gas partition coefficient of desflurane (l) of
each patient (II).
I. Determination of the blood/gas partition coefficient (l)
of desflurane in the blood of each patient. To obtain
standard gas partial pressures, five 550-ml glass bottles, each
with a turnable stopcock and Teflon septum, were used (19).
After flushing each bottle with nitrogen gas for 6 minutes,
each Teflon septum was pierced with a syringe needle, and 2,
5, 10, 20, or 50 ml of liquid desflurane at 10 C˚ was injected
into the bottles. Then, 225 ml of the calculated desflurane
gas was obtained from each bottle and injected into a gas
chromatography (GC) using a gas-tight Hamilton syringe
(Hamilton 250 ml syringe, No. 81156). (Hamilton, Reno, NV,
USA). The calculated volume percent of desflurane was
plotted against the measured gas chromatography counts.
The partial pressure was obtained by calculating the volume
percent/100 6 the barometric pressure. We used a similar
method to that described by Smith et al. (20).
II. Conversion of desflurane liquid to vapor according to
the known l value of desflurane. The physical properties
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of desflurane were calculated as follows: MW/D = volume
for one mole of desflurane liquid; blood/gas partition
coefficient (desflurane) = 0.42 (0.40–0.44); MW = molecular
weight (for desflurane, 168.04); and desflurane density (d) at
10 C˚ = 1.4892. According to the ideal gas law, one mole of
desflurane (MW = 168.04 grams) is equal to 22.4 L of
desflurane vapor at 1 atm pressure and 0 C˚. Therefore,
1 ml of desflurane vapor is equal to 7.50 mg. As the
temperature increases from 0 to 37 C˚, 1 ml of desflurane
vapor should be equal to 6.61 mg, according to the ideal gas
law as follows:
V37C~
273K
273Kz37K
|7:50mg
According to the blood/gas partition coefficient of each
patient, we calculated the amount of desflurane in 1 ml that
would be required to produce a 1% desflurane concentra-
tion in the blood. For example, if lb/g is assumed to be 0.42,
an equilibrated sample of 100 ml of desflurane gas and
100 ml of blood (each at 1% partial pressure) would contain
6.61 mg and 2. mg of desflurane, respectively, at 37 C˚ (1
atm). Therefore, 1 ml of 1% desflurane in blood could be
calculated to contain 0.0281 mg of desflurane. In other
words, the GC count measured from the headspace was
registered as containing 1% of desflurane in the blood after
0.0281 mg of desflurane was injected into a 10-ml vial and
equilibrated with 1 ml of blank blood.
Gas Chromatography Conditions
The HP 6890 series GC system (Hewlett-Packard, Wil-
mington, DE) consisted of a headspace sampler (Agilent
G1888), an oven, a flame-ionization detector, and an inte-
grator. The oven temperature was set at 40 C˚, was increased
at a rate of 25 C˚ per minute to 200 C˚, and was then
maintained at this level for 2.60 min. Both the injection and
detection temperatures were set at 250 C˚. The inlet pressure
was set at 349 kPa. The injection was performed in the direct
injection mode. The carrier gas (helium) flow was 25.0 ml
min-1. Separation was achieved using a capillary column
(HP-5; 30.0 m 0.32 mm I.D., 0.25-mm film thickness) (Restek,
Bellefonte, PA). An integrator and a data acquisition system
were provided by the HP CHEMOSTATION software. The
method used to create calibration curves for measuring the
blood desflurane concentrations was modified, as described
in our previous publication (5).
Statistical analysis
Generalized estimating equations (GEEs) were intro-
duced as a method to deal with correlated data in applied
science (13). Patient characteristics, mean arterial blood
pressure, heart rate, end tidal CO2, cardiac index, CEdes,
and Ades values were presented as the means (SD) for each
of the three groups. GEEs are commonly used to assess
the group, time, and group-by-time effects and to adjust
the correlations arising from repeated measurements.
Moreover, we used estimate and contrast statements to
assess the between-group significant differences at various
times and the within-group variation in Ades for each
group using SAS 9.2 (SAS, Cary, NC). A p-value,0.05 was
considered to represent a significant difference.
RESULTS
Thirty female patients between the ages of 24 and 55 years
(mean age, 43 years) undergoing elective gynecologic
surgery were randomly allocated into the following three
groups: hyperventilation, normal ventilation and hypoven-
tilation. The patient characteristics are shown in Table 1.
There were no significant differences between the three
groups with regard to the hemodynamic parameters,
including arterial pressure, heart rate, cardiac index, and
total peripheral resistance, measured at various time
intervals (Table 2). The ETCO2 values for the three
ventilation groups during first 40 minutes of the study are
displayed in Figure 1. Of the three groups, the mean (SD;
range) ETCO2 value was greatest (significant) in the
hypoventilation group (49.7 [1.9; 46-51] mmHg), followed
by the normal ventilation group (39.3 [1.9; 38-41] mmHg)
and the hyperventilation group (30.1 [1.5; 29-33] mmHg).
The mean (SD; range) value for minute alveolar ventilation
was greatest (significant) in the hyperventilation group
(3334 [(127; 2920-3800] ml.min-1), followed by the normal
ventilation group (2376 [108; 2130-2480] ml.min-1) and the
hypoventilation group (1797 [135; 1642-2081] ml.min-1). The
mean (SD) blood/gas partition coefficient of desflurane (l)
for the 30 patients was 0.42 (0.02).
The Ades values for the three groups during the 40-
minute study are depicted in Figure 2. The arterial
desflurane concentration was highest in the hyperventila-
tion group, followed by the normal ventilation group and
then the hypoventilation group. The pattern of the CEdes-
over-time curves (Figure 3) was similar to that of the Ades-
over-time curves in all three groups. The CEdes value was
highest in the hyperventilation group, followed by the
normal ventilation group and then the hypoventilation
group during the 40-minute study.
There were significant differences in the arterial desflurane
concentrations between the hyperventilation and normal
ventilation groups (p= 0.0342) and between the normal
ventilation and hypoventilation groups (p= 0.0083). In addi-
tion, there was an interaction effect for group-by-time
Table 1 - Patient demographic characteristics for the three ventilation groups.
Characteristic
Hyperventilation
(N=10) Normal ventilation (N=10)
Hypoventilation
(N=10)
Age, years 47.4 (8.0) 42.0 (9.1) 38.8 (10.7)
Weight, kg 61.8 (6.8) 62.0 (10.1) 58.0 (9.3)
Height, cm 160 (8.3) 165 (4.4) 160 (5.7)
BMI, kg m-2 23.7 (3.9) 22.8 (3.1) 22.5 (2.8)
Fentanyl, mg 110 (15) 125 (40) 115 (35)
cis-atracurium, mg 6.6 (0.4) 6.7 (0.5) 6.3 (0.3)
Values are indicated by mean (SD); BMI: Body mass index.
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(hypoventilation vs. normal ventilation, p= 0.029), which
indicated significantly higher levels of the arterial desflurane
concentration over time in the normal ventilation group
compared with the hypoventilation group. Although there
was no overall interaction effect for group-by-time (hyper-
ventilation vs. normal ventilation; Table 3), there were
significant differences in the arterial desflurane concentration
between the hyperventilation and normal groups at the 5th
minute (p= 0.0088) and 10th minute (p= 0.0249) following the
administration of desflurane. The significant differences in
Ades between the hyperventilation and normal ventilation
groups (5th minute: 3.40% and 3.09%, respectively; 10th
minute: 3.68% and 3.44%, respectively) and between the
hypoventilation and normal ventilation groups at the 1st
minute (1.77% and 2.17%, respectively), 3rd minute (2.41%
and 2.83%, respectively), and 10th minute (3.08% and 3.44%,
respectively) following the administration of desflurane are
also shown in Figure 2. The within-group variances for the
arterial desflurane concentration (%) significantly increased in
each group.
Table 2 - Hemodynamic variables for the three ventilation
groups at -10 (10 minutes before the start of the study), 5,
10, 20, 30, and 40 minutes following desflurane
administration.
Time
(min)
Hyperventilation
(n = 10)
Normal ventilation
(n = 10)
Hypoventilation
(n= 10)
MAP (mmHg)
-10 85 (22) 85 (21) 83 (18)
5 71 (14) 75 (17) 77 (14)
10 81 (12) 78 (13) 77 (13)
20 92 (16) 92 (23) 96 (15)
30 98 (22) 95 (15) 93 (13)
40 99 (14) 95 (16) 100 (10)
HR (beat min-1)
-10 74 (9) 80 (31) 82 (18)
5 70 (14) 71 (14) 70 (16)
10 68 (12) 71 (14) 65 (14)
20 59 (11) 67 (13) 72 (14)
30 56 (10) 67 (21) 66 (16)
40 59 (10) 66 (12) 70 (13)
CI (L min-1 m-2)
-10 3.28 (1.16) 3.31 (1.02) 3.35 (0.67)
5 3.01 (0.79) 3.01 (0.82) 3.15 (0.87)
10 3.13 (0.63) 2.98 (0.75) 3.22 (0.89)
20 2.85 (0.53) 2.83 (0.45) 3.22 (0.85)
30 2.86 (1.38) 2.64 (0.60) 3.16 (0.79)
40 2.81 (0.74) 2.78 (0.43) 3.35 (0.89)
TPR (dyne sec cm-5)
-10 1369 (331) 1455 (482) 1275 (331)
5 1336 (276) 1311 (312) 1278 (265)
10 1392 (243) 1335 (240) 1379 (358)
20 1714 (298) 1737 (404) 1595 (417)
30 1939 (544) 1858 (486) 1714 (561)
40 1883 (301) 1744 (351) 1722 (327)
Values are indicated by the means (SD); MAP: mean arterial pressure; HR:
heart rate; CI: cardiac index; TPR: total peripheral resistance.
Figure 1 - End Tidal CO2 concentration (ETCO2) time curves under
three different ventilatory states, including hyperventilation
(--.--), normal ventilation (--m--),and hypoventilation (--g--)
during 40 minutes of study.Data are presented as the mean¡
standard deviation.
Figure 2 - Arterial desflurane concentration (Ades) time curves
under three different ventilatory states, including hyperventila-
tion (--.--), normal ventilation (--m--),and hypoventilation (--g--)
during 40 minutes of study.Data are presented as the mean¡
standard deviation.Statistically significant differences are shown
by * p,0.05 for hyperventilation vs. normal ventilation, and
{ p,0.05 for hypoventilation vs. normal ventilation.
Figure 3 - End-tidal desflurane concentration (CEdes) time curves
under three different ventilatory states, including hyperventila-
tion (--.--), normal ventilation (--m--), and hypoventilation (--g--),
during 40 minutes of study. Data are presented as the mean¡
standard deviation.Statistically significant differences are shown
by * p,0.05 for hyperventilation vs. normal ventilation, and
{p,0.05 for hypoventilation vs. normal ventilation.
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Table 4 displays the slopes of the Ades-over-time curves
for the three ventilation groups. During the first 5 minutes
following the administration of desflurane, there were
significant differences in the slopes of the Ades-over-time
curves between the hyperventilation and normal ventilation
groups (p= 0.0272) and between the hypoventilation and
normal ventilation groups (p= 0.0343).
DISCUSSION
The novel findings of this study concerned the changes in
blood desflurane concentration, which were used to indicate
the desflurane concentration in the brain, under different
ventilation statuses. Our study demonstrated two main
findings. First, hyperventilation significantly accelerated the
rise in the arterial blood concentration of desflurane,
especially during the first 10 minutes following desflurane
administration. In the following 30 minutes, the arterial
concentration of desflurane in the hyperventilation group
remained greatest, despite insignificant significant differ-
ences between groups. Second, the slope of the Ades-over-
time curve, which was used to indicate the uptake of
desflurane into the blood, was significantly greater in the
hyperventilation group but only during the first 5 minutes
following desflurane administration. With comparable
hemodynamic and ventilatory parameters and a fixed
inspired concentration, the changes in the slopes were
determined mainly by alveolar ventilation and were time-
dependent.
Increased alveolar ventilation resulted in a more rapid
change in the desflurane concentration in the Ades and the
CEdes, although the CEdes values obtained were significantly
higher than the Ades values. In comparison to CEdes, the
arterial desflurane concentration is more likely to reflect the
desflurane concentration at its site of action – the brain (5). Our
study demonstrated that hyperventilation produced a higher
arterial blood desflurane concentration than normal ventila-
tion and hypoventilation during the first 10 minutes follow-
ing desflurane administration, which may have provided a
deeper state of anesthesia. In contrast, hypoventilation led
to a slower rise in the Ades and provided a lower level of
anesthesia.
To understand how ventilation affects Ades, it is necessary
to examine the slope of the Ades-over-time curves as well as
the time required for desflurane to achieve the functional
residual capacity (FRC). Changes in the slope of the Ades-
over-time curves represent changes in the rate of desflurane
passage into the arterial blood over time, whereas CIdes
represents the inspiratory desflurane concentration at the
mouth, and the inspiratory alveolar desflurane concentration
indicates the inspiratory concentration of desflurane in the
alveoli. At the time of desflurane administration, there was
no desflurane vapor in the existing FRC at time 0. Moreover,
a breathing circuit (estimated 6 L in a Datex AS/5 anesthetic
machine) should be filled in 1 minute by 6 L min-1 of fresh
gas flow with a fixed 6% inspired desflurane concentration,
which is followed by the immediate entry of the inspired
desflurane into the existing space of the FRC, and the
desflurane concentration is then diluted by the existing air in
the alveolar space. The inspiratory alveolar desflurane
concentration decreases because the volume of the FRC is
much larger than the tidal volume. Thus, there is only a very
small amount of desflurane to be delivered from the alveoli to
the pulmonary capillary blood (a relatively small concentra-
tion gradient between the pulmonary capillary circulating
blood and alveolar desflurane) during the initial desflurane
administration. As ventilation proceeds, the alveolar con-
centration of desflurane rises rapidly, depending on the
volume of alveolar ventilation, to deliver the desflurane from
the alveoli into the pulmonary capillary blood and subse-
quently the arterial blood. The slope of the Ades-over-time
curve was largest at the onset of desflurane administration
and became smaller over time and approached zero for each
group. The greatest concentration gradient of desflurane
occurred between the alveoli and pulmonary capillary blood
under hyperventilation compared to normal ventilation or
hypoventilation, which likely hastened the passage of
desflurane into the circulating blood during the initial
administration of desflurane.
Table 3 - Generalized estimating equation analysis for the arterial desflurane concentrations between the
hyperventilation and hypoventilation groups compared with the normal group.
Empirical Standard Error Estimates
Variable Group Estimate Standard Error 95% Confidence Limits Z p-value
Intercept 2.63 0.08 2.47/2.79 32.27 ,0.0001
Group effect Hyperventilation vs. Normal ventilation 0.19 0.09 0.01/0.37 2.12 0.0342
Hypoventilation vs. Normal ventilation -0.40 0.15 -0.70/-0.10 -2.64 0.0083
Time effect Normal ventilation 0.03 0.00 0.03/0.03 15.00 ,0.0001
Group*
time effect
Hyperventilation vs. Normal ventilation 0.00 0.00 -0.01/0.00 -0.83 0.4063
Hypoventilation vs. Normal ventilation 0.01 0.00 0.00/0.01 2.18 0.0290
The model has been adjusted for age and BMI.
Data were assessed using PROC GENMOD (SAS 9.2 v.).
Table 4 - Mean (SD) values for the slopes of Ades-over-time curves in the three groups at different time periods.
Ventilation 1,5 min 5,10 min 10,20 min 20,40 min
Hyperventilation 0.299 (0.012) * 0.027 (0.014) 0.016 (0.01) 0.002 (0.01)
Normal ventilation 0.230 (0.006) 0.035 (0.007) 0.022 (0.017) 0.008 (0.009)
Hypoventilation 0.193 (0.007) { 0.041 (0.027) 0.041 (0.023) 0.009 (0.011)
Statistically significant differences are shown by * p,0.05 for hyperventilation vs. normal ventilation and { p,0.05.
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Increased ventilation causes a more rapid rise in the CEdes
because the FRC wash-in is more rapid and the time constant
(FRC/alveolar ventilation) becomes shorter (5), and vice
versa. For the calculation, one time constant is derived from
the value of the FRC divided by the minute alveolar
ventilation. Assuming that the FRC is equal to 2,400 mL in
Taiwanese female adults in the supine position (14,15) and
the mean alveolar ventilation in the hypoventilation group is
1.793 ml min-1, one time constant for the FRC wash-in should
be 1.39 minutes (2400 ml/1793 ml min-1) (16-18). The time
needed to achieve 99% FRC filling was therefore 7.0 minutes
(1.34 minutes 6 5 time constants) in the hypoventilation
group. For the normal ventilation and hyperventilation
groups, these values were calculated to be 5 minutes (1.0
minutes65 time constants) and 3.6 minutes (0.72 minutes65
time constants), respectively. With the addition of one minute
to fill the breathing circuit during the initial administration of
desflurane, the estimated differences in the time needed to fill
the FRC could explain why the different levels of ventilation
produced different effects on the slopes of the Ades-over-
time curves, especially during the initial 10 minutes of the
study. During the last 30 minutes of the study, the impact of
alveolar ventilation on the slope of the Ades-over-time curves
disappeared because FRC fill-up was achieved. The effect of
alveolar ventilation on the change in the slope of the Ades-
over-time curve was time-dependent during desflurane
anesthesia.
In conclusion, hyperventilation accelerates the uptake of
desflurane within the initial 10 minutes after intubation by
achieving higher arterial concentrations. This increased
alveolar ventilation also hastens the wash-in of the
functional residual capacity to provide more rapid target
control of anesthetic depth, which is time-dependent.
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